IFNG and arthritic joint disease: Consistent with arthritis severity scores, neutralizing antibody to IL-17 completely protected the joints of mice treated with anti-IFN-γ but had no effect on the severe joint inflammation and destruction observed in mice treated with anti-IFN-γ and anti-IL-4 (Figure 6D).